Navigation Links
Synthetic platelet maker receives innovator award
Date:9/30/2010

A Case Western Reserve University researcher will receive a $2.3 million New Innovator Award today to further develop and broaden the uses of synthetic platelets and the technology that makes them work.

Erin Lavik, associate professor of biomedical engineering, uses nanotechnology to build platelets of biodegradable polymers, which link with natural platelets to stem bleeding faster.

She and fellow researchers initially pursued the technology after seeing the damage and death tolls among soldiers who received traumatic brain injuries in Afghanistan and Iraq.

The award, presented by the National Institutes of Health, is designed specifically to support unusually creative new investigators with highly innovative research ideas at an early stage of their career.

"It will provide a wonderful foundation for supporting my students as we pursue this research," Lavik said.

Lavik's lab will continue testing and fine-tuning the artificial platelets toward use in people suffering all kinds of traumatic injuries. She also plans to develop new modes of drug delivery based on the system the synthetic platelets use to home in and lock onto clotting natural platelets.

"NIH is pleased to be supporting early-stage investigators from across the country who are taking considered risks in a wide range of areas in order to accelerate research," said Francis S. Collins, M.D., Ph.D., director of the National Institutes. "We look forward to the results of their work."


'/>"/>

Contact: Kevin Mayhood
kevin.mayhood@case.edu
216-368-4442
Case Western Reserve University
Source:Eurekalert

Page: 1

Related medicine news :

1. Chemotherapy plus synthetic compound provides potent anti-tumor effect in pancreatic cancers
2. Chemo Plus Synthetic Drug Shrunk Pancreatic Tumors
3. Synthetic eye prosthesis
4. Surf Sweets Among Few Candy Offerings Free of Synthetic Dyes Despite Growing Consumer Concern Over Affect on Children
5. Biosynthetic Corneas Show Promise in Transplants
6. Synthetic lethality strategy improves molecularly targeted cancer therapy
7. Low-Dose Platelet Transfusions Deemed Safe
8. Fewer platelets could be used for some cancer and bone-marrow transplantation patients
9. New York Sports Medicine Offers Platelet Rich Plasma Therapy For Treatment of Injury
10. After Teeth Are Pulled, Platelet-Rich Plasma May Speed Healing
11. Overactive Blood Platelets May Play Role in Lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... In just a short ... has already been receiving positive feedback from customers trying the product for the first ... Daily Brain Booster was developed by neurosurgeon Shawn Moore, MD, for everyone from athletes ...
(Date:9/20/2017)... ... 2017 , ... Five consumer packaged goods (CPG) products were selected by the ... Nopavera Plus was named to the short list in the Specialty Supplements ... during presentations at SupplySide Central on Sept. 27 and 28 at Mandalay Bay Resort ...
(Date:9/20/2017)... ... September 20, 2017 , ... Medicare doesn’t ... risk of price gouging for their prescription drugs, according to a new comparison ... isn’t negotiating on our behalf, there’s no consistency in drug pricing among drug ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... poor, the new feel good program from Leany Greeny delivers positive results in ... can rejuvenate overall health and kickstart the metabolism. Fitting seamlessly into hectic work ...
(Date:9/20/2017)... ... September 20, 2017 , ... “RECYCLED ... “RECYCLED Ezekiel's Plan for Freedom from ADDICTION” is the creation of published author, ... field of addiction and homeless services, including more than a decade of addiction ...
Breaking Medicine News(10 mins):
(Date:9/1/2017)... Mass. , Sept. 1, 2017 ... HealthCare Solutions, Inc , highlights opportunities for growth in ... Journal report that Marlin Equity is seeking a buyer ... an annual award-winning 22-year-old healthcare solutions Value Added Reseller ... "As the healthcare ...
(Date:9/1/2017)... Sept. 1, 2017  Bayer will present the latest research ... for Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... new preclinical and clinical data on Bayer,s marketed portfolio and ... projects. "We value ... in cancer research at ESMO," said Carsten Brunn , ...
(Date:8/29/2017)... ivWatch, LLC, the leading provider of continuous monitoring devices ... been awarded an Innovative Technology contract from Vizient, Inc., the largest ... ... the early detection of peripheral IV infiltration and extravasation events ... The Innovative Technology contract was awarded to ivWatch ...
Breaking Medicine Technology: